Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials
- PMID: 32823372
- PMCID: PMC7948251
- DOI: 10.1002/sim.8721
Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials
Abstract
Cluster randomized trials (CRTs) refer to experiments with randomization carried out at the cluster or the group level. While numerous statistical methods have been developed for the design and analysis of CRTs, most of the existing methods focused on testing the overall treatment effect across the population characteristics, with few discussions on the differential treatment effect among subpopulations. In addition, the sample size and power requirements for detecting differential treatment effect in CRTs remain unclear, but are helpful for studies planned with such an objective. In this article, we develop a new sample size formula for detecting treatment effect heterogeneity in two-level CRTs for continuous outcomes, continuous or binary covariates measured at cluster or individual level. We also investigate the roles of two intraclass correlation coefficients (ICCs): the adjusted ICC for the outcome of interest and the marginal ICC for the covariate of interest. We further derive a closed-form design effect formula to facilitate the application of the proposed method, and provide extensions to accommodate multiple covariates. Extensive simulations are carried out to validate the proposed formula in finite samples. We find that the empirical power agrees well with the prediction across a range of parameter constellations, when data are analyzed by a linear mixed effects model with a treatment-by-covariate interaction. Finally, we use data from the HF-ACTION study to illustrate the proposed sample size procedure for detecting heterogeneous treatment effects.
Keywords: cluster randomized trials; heterogeneous treatment effect; interaction; intraclass correlation coefficient; power formula; sample size estimation.
© 2020 John Wiley & Sons Ltd.
Figures



Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity.Stat Med. 2022 Apr 15;41(8):1376-1396. doi: 10.1002/sim.9283. Epub 2021 Dec 19. Stat Med. 2022. PMID: 34923655 Free PMC article.
-
Design and analysis of cluster randomized trials with time-to-event outcomes under the additive hazards mixed model.Stat Med. 2022 Oct 30;41(24):4860-4885. doi: 10.1002/sim.9541. Epub 2022 Jul 31. Stat Med. 2022. PMID: 35908796 Free PMC article.
-
Sample size calculators for planning stepped-wedge cluster randomized trials: a review and comparison.Int J Epidemiol. 2022 Dec 13;51(6):2000-2013. doi: 10.1093/ije/dyac123. Int J Epidemiol. 2022. PMID: 35679584 Free PMC article. Review.
-
Reporting and methodological quality of sample size calculations in cluster randomized trials could be improved: a review.J Clin Epidemiol. 2015 Jun;68(6):716-23. doi: 10.1016/j.jclinepi.2014.10.006. Epub 2014 Dec 15. J Clin Epidemiol. 2015. PMID: 25523375 Review.
Cited by
-
Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials.Stat Methods Med Res. 2024 May;33(5):909-927. doi: 10.1177/09622802241242323. Epub 2024 Apr 3. Stat Methods Med Res. 2024. PMID: 38567439 Free PMC article.
-
Power Analysis for Moderator Effects in Longitudinal Cluster Randomized Designs.Educ Psychol Meas. 2023 Feb;83(1):116-145. doi: 10.1177/00131644221077359. Epub 2022 Feb 28. Educ Psychol Meas. 2023. PMID: 36601251 Free PMC article.
-
Using Power Analysis to Choose the Unit of Randomization, Outcome, and Approach for Subgroup Analysis for a Multilevel Randomized Controlled Clinical Trial to Reduce Disparities in Cardiovascular Health.Prev Sci. 2024 Jul;25(Suppl 3):433-445. doi: 10.1007/s11121-024-01673-y. Epub 2024 May 20. Prev Sci. 2024. PMID: 38767783 Free PMC article.
-
Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review.Alzheimers Dement (Amst). 2023 Feb 5;15(1):e12392. doi: 10.1002/dad2.12392. eCollection 2023 Jan-Mar. Alzheimers Dement (Amst). 2023. PMID: 36777091 Free PMC article.
-
Designing three-level cluster randomized trials to assess treatment effect heterogeneity.Biostatistics. 2023 Oct 18;24(4):833-849. doi: 10.1093/biostatistics/kxac026. Biostatistics. 2023. PMID: 35861621 Free PMC article.
References
-
- Murray D. Design and Analysis of Group-Randomized Trials. New York, NY: Oxford University Press; 1998.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous